UNICA IRIS Institutional Research Information System

DE LOGU, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 172.345
NA - Nord America 9.645
AS - Asia 4.659
SA - Sud America 683
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 7
Totale 187.446
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 168.699
US - Stati Uniti d'America 9.476
SG - Singapore 1.872
CN - Cina 1.785
UA - Ucraina 1.050
DE - Germania 610
SE - Svezia 602
FI - Finlandia 560
BR - Brasile 504
VN - Vietnam 350
GB - Regno Unito 301
FR - Francia 277
HK - Hong Kong 133
IN - India 117
KR - Corea 113
CA - Canada 86
MX - Messico 67
BD - Bangladesh 51
AR - Argentina 47
MA - Marocco 45
RU - Federazione Russa 44
EC - Ecuador 41
NL - Olanda 40
IQ - Iraq 38
JP - Giappone 27
CO - Colombia 25
TR - Turchia 25
BE - Belgio 22
ES - Italia 22
ID - Indonesia 22
PL - Polonia 22
ZA - Sudafrica 19
PE - Perù 18
PK - Pakistan 18
VE - Venezuela 15
UZ - Uzbekistan 12
CH - Svizzera 11
IE - Irlanda 11
PH - Filippine 11
SA - Arabia Saudita 11
AT - Austria 10
CL - Cile 10
IL - Israele 10
MD - Moldavia 10
PY - Paraguay 10
EG - Egitto 9
KE - Kenya 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
TN - Tunisia 7
AL - Albania 6
EU - Europa 6
JO - Giordania 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
BY - Bielorussia 4
HU - Ungheria 4
KZ - Kazakistan 4
SM - San Marino 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
LT - Lituania 3
MU - Mauritius 3
OM - Oman 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CG - Congo 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
ET - Etiopia 1
Totale 187.434
Salva come PNG Salva come JPEG
Città #
Cagliari 164.153
Uta 3.055
Singapore 855
Chandler 764
Ashburn 747
Woodbridge 634
Fairfield 625
Jacksonville 597
Boardman 568
Ann Arbor 491
San Jose 489
Dallas 451
Houston 406
Nyköping 406
Helsinki 403
Wilmington 327
Beijing 259
Munich 257
Seattle 257
New York 231
Los Angeles 220
Cambridge 214
Hefei 209
Boston 181
Nanjing 162
Lauterbourg 139
Santa Clara 132
Dearborn 125
Hong Kong 120
Ho Chi Minh City 117
Seoul 112
Milan 104
Buffalo 90
The Dalles 86
Shanghai 85
Rome 83
Hanoi 79
Redwood City 68
Shenyang 61
Nanchang 59
Chicago 58
Toronto 58
Tianjin 57
Hebei 49
Verona 48
Changsha 45
São Paulo 44
Guangzhou 36
San Diego 35
Jiaxing 33
Casablanca 30
Council Bluffs 30
Orange 30
Atlanta 29
Chennai 28
London 28
Zhengzhou 28
Jinan 26
Washington 26
Orem 24
Norwalk 23
Ningbo 21
Florence 19
Redondo Beach 19
Tokyo 19
Brussels 18
Bologna 17
Brooklyn 17
Nuremberg 17
Elk Grove Village 16
Rio de Janeiro 16
Frankfurt am Main 15
Quito 15
Sassari 15
Warsaw 15
Auburn Hills 14
Dhaka 14
Genoa 14
Hangzhou 14
Johannesburg 14
Haiphong 13
Mountain View 13
Saint Petersburg 12
Salt Lake City 12
Baghdad 11
Caserta 11
Curitiba 11
Da Nang 11
Jyväskylä 11
Naples 11
Palermo 11
Phoenix 11
Pune 11
Turin 11
Turku 11
Amsterdam 10
Catania 10
Cedar Knolls 10
San Francisco 10
Sìnnai 10
Totale 179.716
Salva come PNG Salva come JPEG
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.056
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.606
Limonoids from Melia azedarach fruits as inhibitors of flaviviruses and mycobacterium tubercolosis 4.484
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.406
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases 3.497
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells 3.063
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 2.764
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 2.374
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 2.329
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 2.267
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. 2.246
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection 2.204
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach 2.193
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.180
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa 2.158
Imidazole and 1,2,4-triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment 2.108
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.104
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.098
Improving the physical chemical properties of a very promising class of pyrrole antimycobacterial agents 2.047
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 2.002
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.999
In vivo potent BM635 analogue with improved drug-like properties 1.979
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation 1.957
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.954
null 1.953
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.929
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug 1.916
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.915
null 1.829
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.813
Nuove strategie per lo sviluppo di farmaci antitubercolari: caratterizzazione di target alternativi e di fattori di virulenza in Mycobacterium tuberculosis 1.798
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis 1.792
Sherris. Microbiologia medica 1.771
null 1.749
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari 1.683
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.662
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.652
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.640
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.609
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.595
Phenazine-1-carboxilyc acid derivatives suppressing the RNA polymerase as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.551
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.547
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.513
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 1.476
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero 1.470
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.468
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.457
dentification of a new Chemical Class of Potent Antimycobacterial Compounds 1.439
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 1.427
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis 1.405
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. 1.363
Nuovo sistema di fermentazione in semi-solido per la produzione di enzimi cellulosolitici 1.347
Infezioni nosocomiali da Pseudomonas maltophilia in un reparto di terapia intensiva per neonat 1.282
Sul trattamento microbiologico delle acque di vegetazione 1.281
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.271
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini 1.238
Saggi e dosaggi microbiologici della Farmacopea 1.233
Studio di un metodo rapido mediante riduzione di XTT per la determinazione della resistenza in Mycobacterium tuberculosis 1.220
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 1.190
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 1.170
null 1.144
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.129
Antimycobacterial Activiy of New 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues 1.123
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 1.108
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.076
null 1.070
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 1.039
In vitro antiviral activity of liposomal Artemisia arborescens essential oil 1.035
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.034
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. 998
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 996
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 974
null 935
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 909
PHISICAL STABILITY OF ARTEMISIA ARBORESCENS L. ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 907
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 862
null 826
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 821
null 818
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 803
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 784
null 764
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 763
Aspetti Microbiologici della Produzione Farmaceutica 747
null 736
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 706
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 699
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 687
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 656
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 654
Degradazione biologica degli aghi di pino (Pinus Silvester) 649
Liposomes as carrier for Artemisia arborescens essential oil: preparation, characterisation and antiviral activity 646
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi. 643
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 621
Aspetti microbiologici della produzione farmaceutica 608
Saggi e dosaggi microbiologici della Farmacopea 606
null 605
PHYSICAL STABILITY OF ARTEMISIA ARBORESCENS ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 583
Stafilococchi 578
Totale 154.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.100 0 0 0 0 0 0 0 0 0 2.050 1.688 1.362
2021/20228.886 1.427 908 478 567 715 541 389 529 756 769 902 905
2022/202312.524 1.314 1.647 1.447 886 818 1.183 645 1.462 742 620 954 806
2023/202416.879 940 523 1.037 1.211 1.661 3.247 2.625 943 684 1.201 1.491 1.316
2024/202534.953 7.713 11.595 4.674 2.829 1.715 1.663 2.824 277 451 317 443 452
2025/20268.462 490 699 1.088 1.127 500 599 1.264 1.104 663 928 0 0
Totale 187.695